Turkish regulator fines a number of huge drugmakers for ‘no-poach’ agreements
Antitrust regulators in Turkey have fined greater than a dozen massive pharmaceutical firms — together with international drugmakers corresponding to Pfizer, AstraZeneca, and Novartis — for agreeing to not poach workers from each other, a transfer that disrupted the home labor market.
The Turkish Competitors Authority additionally discovered that a number of the firms shared competitively delicate details about future salaries and advantages. Each practices violated competitors legal guidelines and resulted in fines totaling about $5.6 million on the 17 firms that engaged in anticompetitive conduct.
In a transient assertion, the regulator mentioned these practices undermine competitors within the pharmaceutical sector and disrupt worker mobility, which might result in synthetic constraints on salaries and profession alternatives. In doing so, the businesses didn’t foster a aggressive atmosphere that would profit society, the regulator mentioned.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
